Study of Eating Patterns with a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome

NCT ID: NCT03241121

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

235 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-29

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

SwissChronoFood - Study of eating patterns with a smartphone app and the metabolic effects of time restricted feeding in metabolic syndrome

The purpose of this study is to assess eating patterns among teenagers and adults with a new method, going beyond the pen-and-paper food diaries, and to investigate whether time restricted feeding leads to weight loss, improvement in lipid and glucose metabolism in individuals with components of the metabolic syndrome

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prevalence of the metabolic syndrome (MS) is increasing worldwide, due to the progression of its different components (central obesity, elevated blood pressure, impaired glucose tolerance and dyslipidemia), as well as the often associated liver steatosis. One way to tackle the obesity epidemic is to intervene early at the onset in childhood and teenage years - before cardio-metabolic complications have occurred. However, lifestyle programs targeting this age group had limited success in the current obesogenic environment. In particular, weight loss is a key factor in controlling all MS components, yet it is difficult to maintain over time.

Time restricted feeding (TRF) is an approach that emphasizes energy intake limited to certain windows of time within the 24-hour cycle without restrictions on calories or macronutrients. This has emerged as an appealing approach to reduce body weight while improving lipid profile and glucose metabolism. However, TRF has been mostly studied in animals and long-term prospective data on its efficacy and mechanisms in humans is lacking.

Prior to the intervention, the investigators will assess the eating patterns of participants with an innovative smartphone application ('app') which is less intrusive and more reliable than food diaries/questionnaires to assess eating behavior and patterns.

In this project, the investigators will assess eating patterns among teenagers and adults, and investigate whether a controlled TRF intervention leads to beneficial changes in MS components. Study Part 1 uses an epidemiological approach to establish baseline daily eating behavior, physical activity patterns and sleeping habits over 2 weeks (teenagers) and 4 weeks (adults) using the smartphone app. Those individuals meeting criteria for at least one component of MS and who have eaten for \>14 hours per 24-hour cycle will be recruited for Study Part 2. In Part 2, participants will be assigned to TRF or active control groups, and followed in this pragmatic randomized controlled trial for 6 weeks (teenagers) and 6 months (adults) to assess the change in their weight and MS components, as well as liver fat deposits. Study Part 3 will investigate the underlying mechanisms of improved metabolic profile with TRF.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eating Behavior Metabolic Syndrome Obesity Dyslipidemias Glucose Intolerance Steatosis of Liver

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Time Restricted Feeding Eating patterns

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Study Part 1: Prospective longitudinal observational study. Study Part 2/3: Open-label randomized controlled trial.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Time restricted feeding

For those in the intervention phase (Part 2)

Group Type EXPERIMENTAL

Time restricted feeding

Intervention Type BEHAVIORAL

To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake

Eating patterns

Intervention Type DEVICE

Data collection on eating patterns via the smartphone app

Regular dietary advices

For those in the intervention phase (Part 2)

Group Type ACTIVE_COMPARATOR

Regular dietary advices

Intervention Type BEHAVIORAL

Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines

Eating patterns

Intervention Type DEVICE

Data collection on eating patterns via the smartphone app

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time restricted feeding

To eat only during a self-selected window of 12 hours, with no advice on nutrition quality, quantity or caloric intake

Intervention Type BEHAVIORAL

Regular dietary advices

Regular dietary advices by a trained dietitian or research nurse according to current nutrition guidelines

Intervention Type BEHAVIORAL

Eating patterns

Data collection on eating patterns via the smartphone app

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 12 years
* Body mass index ≥ 20 kg/m2 and stable weight (previous 3 months) in adults; BMI ≥ 25th percentile in teenagers
* Smartphone compatible with the app (iOS or Android systems)


* Any component of the metabolic syndrome following the International Diabetes Federation consensus definition
* Eating duration \>14h during the observation phase


* Age 18-40 years, men and pre-menopausal women
* BMI 30-40 kg/m2
* In the fasting state (at least 8 hours)

Exclusion Criteria

* Pregnant and breastfeeding women, plans for maternity during the study
* Major illness/fever over the previous month, active cancer
* Eating disorder, on a diet / weight management, prior bariatric surgery
* Major mental illness, unable to give informed consent
* Current shift work or travel abroad planned in the next month


* Prior cardiovascular event
* Major liver, gastrointestinal, renal or endocrine disorder, diabetes mellitus with hypoglycemic drug(s)
* Major sleep disorder, centrally acting medication
* Lipid lowering drug, hypoglycemic drug, medication affecting the gut


* Impaired glucose tolerance (pre-diabetes) or diabetes mellitus
* Positive pregnancy test
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Salk Institute for Biological Studies

OTHER

Sponsor Role collaborator

University of Lausanne Hospitals

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tinh-Hai Collet, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tinh-Hai Collet, MD

Role: PRINCIPAL_INVESTIGATOR

University of Lausanne Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inselspital, Klinik für Allgemeine Innere Medizin

Bern, Canton of Bern, Switzerland

Site Status

University Hospital of Lausanne (CHUV)

Lausanne, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Buso G, Favre L, Vionnet N, Gonzalez-Rodriguez E, Hans D, Puder JJ, Dubath C, Eap CB, Raffoul W, Collet TH, Mazzolai L. Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema. Obes Facts. 2022;15(6):762-773. doi: 10.1159/000527138. Epub 2022 Oct 28.

Reference Type BACKGROUND
PMID: 36310013 (View on PubMed)

Phillips NE, Mareschal J, Schwab N, Manoogian ENC, Borloz S, Ostinelli G, Gauthier-Jaques A, Umwali S, Gonzalez Rodriguez E, Aeberli D, Hans D, Panda S, Rodondi N, Naef F, Collet TH. The Effects of Time-Restricted Eating versus Standard Dietary Advice on Weight, Metabolic Health and the Consumption of Processed Food: A Pragmatic Randomised Controlled Trial in Community-Based Adults. Nutrients. 2021 Mar 23;13(3):1042. doi: 10.3390/nu13031042.

Reference Type BACKGROUND
PMID: 33807102 (View on PubMed)

Borloz S, Bucher Della Torre S, Collet TH, Jotterand Chaparro C. Consumption of Ultraprocessed Foods in a Sample of Adolescents With Obesity and Its Association With the Food Educational Style of Their Parent: Observational Study. JMIR Pediatr Parent. 2021 Nov 15;4(4):e28608. doi: 10.2196/28608.

Reference Type BACKGROUND
PMID: 34779776 (View on PubMed)

Papageorgiou M, Biver E, Mareschal J, Phillips NE, Hemmer A, Biolley E, Schwab N, Manoogian ENC, Gonzalez Rodriguez E, Aeberli D, Hans D, Pot C, Panda S, Rodondi N, Ferrari SL, Collet TH. The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial. Obesity (Silver Spring). 2023 Feb;31 Suppl 1(Suppl 1):85-95. doi: 10.1002/oby.23577. Epub 2022 Oct 14.

Reference Type BACKGROUND
PMID: 36239695 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PZ00P3-167826

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

SSED-YI 2017

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2017-00487

Identifier Type: -

Identifier Source: org_study_id